239 related articles for article (PubMed ID: 14749532)
1. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S
Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532
[TBL] [Abstract][Full Text] [Related]
2. Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation.
Galbiati F; Volonte D; Engelman JA; Scherer PE; Lisanti MP
J Biol Chem; 1999 Oct; 274(42):30315-21. PubMed ID: 10514527
[TBL] [Abstract][Full Text] [Related]
3. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
4. A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
Smythe GM; Eby JC; Disatnik MH; Rando TA
J Cell Sci; 2003 Dec; 116(Pt 23):4739-49. PubMed ID: 14600260
[TBL] [Abstract][Full Text] [Related]
5. Limb-girdle muscular dystrophy in a 71-year-old woman with an R27Q mutation in the CAV3 gene.
Figarella-Branger D; Pouget J; Bernard R; Krahn M; Fernandez C; Lévy N; Pellissier JF
Neurology; 2003 Aug; 61(4):562-4. PubMed ID: 12939441
[TBL] [Abstract][Full Text] [Related]
6. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
7. Variable reduction of caveolin-3 in patients with LGMD2B/MM.
Walter MC; Braun C; Vorgerd M; Poppe M; Thirion C; Schmidt C; Schreiber H; Knirsch UI; Brummer D; Müller-Felber W; Pongratz D; Müller-Höcker J; Huebner A; Lochmüller H
J Neurol; 2003 Dec; 250(12):1431-8. PubMed ID: 14673575
[TBL] [Abstract][Full Text] [Related]
8. Intracellular localization of dysferlin and its association with the dihydropyridine receptor.
Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S
Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic dysferlin gene mutation carriers: characterization of two cases.
Illa I; De Luna N; Domínguez-Perles R; Rojas-García R; Paradas C; Palmer J; Márquez C; Gallano P; Gallardo E
Neurology; 2007 Apr; 68(16):1284-9. PubMed ID: 17287450
[TBL] [Abstract][Full Text] [Related]
10. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
11. Membrane repair defects in muscular dystrophy are linked to altered interaction between MG53, caveolin-3, and dysferlin.
Cai C; Weisleder N; Ko JK; Komazaki S; Sunada Y; Nishi M; Takeshima H; Ma J
J Biol Chem; 2009 Jun; 284(23):15894-902. PubMed ID: 19380584
[TBL] [Abstract][Full Text] [Related]
12. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease.
Kubisch C; Schoser BG; von Düring M; Betz RC; Goebel HH; Zahn S; Ehrbrecht A; Aasly J; Schroers A; Popovic N; Lochmüller H; Schröder JM; Brüning T; Malin JP; Fricke B; Meinck HM; Torbergsen T; Engels H; Voss B; Vorgerd M
Ann Neurol; 2003 Apr; 53(4):512-20. PubMed ID: 12666119
[TBL] [Abstract][Full Text] [Related]
13. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy.
Tateyama M; Aoki M; Nishino I; Hayashi YK; Sekiguchi S; Shiga Y; Takahashi T; Onodera Y; Haginoya K; Kobayashi K; Iinuma K; Nonaka I; Arahata K; Itoyama Y
Neurology; 2002 Jan; 58(2):323-5. PubMed ID: 11805270
[TBL] [Abstract][Full Text] [Related]
14. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
[TBL] [Abstract][Full Text] [Related]
15. AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.
Huang Y; Laval SH; van Remoortere A; Baudier J; Benaud C; Anderson LV; Straub V; Deelder A; Frants RR; den Dunnen JT; Bushby K; van der Maarel SM
FASEB J; 2007 Mar; 21(3):732-42. PubMed ID: 17185750
[TBL] [Abstract][Full Text] [Related]
16. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
[TBL] [Abstract][Full Text] [Related]
17. Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3.
Hernández-Deviez DJ; Martin S; Laval SH; Lo HP; Cooper ST; North KN; Bushby K; Parton RG
Hum Mol Genet; 2006 Jan; 15(1):129-42. PubMed ID: 16319126
[TBL] [Abstract][Full Text] [Related]
18. Two novel CAV3 gene mutations in Japanese families.
Sugie K; Murayama K; Noguchi S; Murakami N; Mochizuki M; Hayashi YK; Nonaka I; Nishino I
Neuromuscul Disord; 2004 Dec; 14(12):810-4. PubMed ID: 15564037
[TBL] [Abstract][Full Text] [Related]
19. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
Bönnemann CG; Finkel RS
Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
[TBL] [Abstract][Full Text] [Related]
20. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
